 Germline gene therapy results in any change being inheritable, which has raised concerns within the scientific community.In 2015, CRISPR was used to edit the DNA of non-viable human embryos.In November 2018, He Jiankui announced that he had edited the genomes of two human embryos, in an attempt to disable the "CCR5" gene, which codes for a receptor that HIV uses to enter cells.